Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. News Desk 2018 Message Board

Elsevier Launches New Stem Cell Book Series CAMBRI

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 617763
(Total Views: 133)
Posted On: 05/23/2017 4:00:03 AM
Avatar
Posted By: News Desk 2018
Elsevier Launches New Stem Cell Book Series

CAMBRIDGE, MA --(Marketwired - May 23, 2017) - Elsevier , the information analytics company specializing in science and health, today announced a new book series, Advances in Stem Cells and their Niches . This series addresses stem cells during development, homeostasis, and disease or injury of the respective organs, presenting new developments in the field, including new data on disease and clinical applications. The first volume in the series, Hematopoietic Stem Cell Niche , is available now. Elsevier also announced the publication of six additional genetics, genomics and stem cell medicine books.

Each volume in the Advances in Stem Cells and their Niches series focuses on an individual organ, looking at the stem cells in that organ itself (if they exist), their niches, and how to use them alongside relevant methods and protocols. Edited by Dominique Bonnet, the new series includes video content illustrating such areas as protocols, transplantation techniques, and work with mice.

Learn more about stroma cell niche regulation during HSC development in this sample chapter from Volume 1.

Dr. Dominique Bonnet is a senior group leader at the Francis Crick Institute in London. Her group is investigating the molecular programs that regulate both human normal and leukemic stem cells. She is also interested in deciphering the role played by the microenvironment or niche in this regulation and finding new potential targets to eradicate the leukemic stem cell pool. Dr. Bonnet is also a professor at the University College of London and a senior lecturer at the Institute of Child Health.

The seven new genetics, genomics and stem cell titles are:

  • Hematopoietic Stem Cell Niche , edited by Dominique Bonnet
  • T-box Genes in Development and Disease , edited by Manfred Frasch
  • Polycomb Group Proteins by Vincenzo Pirrotta
  • Epigenetics and Systems Biology by Leonie Ringrose
  • Genomic and Precision Medicine: Primary Care, Third Edition , edited by Geoffrey Ginsburg, Huntington Willard and Sean David
  • It's in Your DNA: From Discovery to Structure, Function and Role in Evolution, Cancer and Aging by Eugene Rosenberg
  • Handbook of Epigenetics: The New Molecular and Medical Genetics, Second Edition , edited by Trygve Tollefsbol

In order to meet content needs in genetics, genomics and stem cell medicine, Elsevier uses proprietary tools to identify the gaps in coverage of the topics. Editorial teams strategically fill those gaps with content written by key influencers in the field, giving students, faculty and researchers the content they need to answer challenging questions and improve outcomes. These new books, which will educate the next generation of geneticists and genomicists, and provide critical foundational content for information professionals, are key examples of how Elsevier is enabling science to drive innovation.

---

Note for Editors Only credentialed media can request eBook review copies by email, sciencereviewcopies@elsevier.com

About Elsevier Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect , Scopus , ClinicalKey and Sherpath . Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell , more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy . Elsevier is part of RELX Group , a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com

Image Available: http://www.marketwire.com/library/MwGo/2017/5...c71538.jpg

Media Contact Pam Foote Publicity Contact, Science & Technology Books, Elsevier footep@reedelsevier.com +1-978-837-8182



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us